IL-33 Induces Cellular and Exosomal miR-146a Expression as a Feedback Inhibitor of Mast Cell Function
The Journal of Immunology · 15.04.2024 · 212 (8) · 1277-1286
DOI: 10.4049/jimmunol.2200916 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 21.02.2024. Verfasst von Marcela T Taruselli und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Virginia Commonwealth University, Richmond, VA. Hauptthemen laut MEDLINE: Asthma, MicroRNAs. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
IL-33 is an inflammatory cytokine that promotes allergic disease by activating group 2 innate lymphoid cells, Th2 cells, and mast cells. IL-33 is increased in asthmatics, and its blockade suppresses asthma-like inflammation in mouse models. Homeostatic control of IL-33 signaling is poorly understood. Because the IL-33 receptor, ST2, acts via cascades used by the TLR family, similar feedback mechanisms may exist. MicroRNA (miR)-146a is induced by LPS-mediated TLR4 signaling and serves as a feedback inhibitor. Therefore, we explored whether miR-146a has a role in IL-33 signaling. IL-33 induced cellular and exosomal miR-146a expression in mouse bone marrow–derived mast cells (BMMCs). BMMCs transfected with a miR-146a antagonist or derived from miR-146a knockout mice showed enhanced cytokine expression in response to IL-33, suggesting that miR-146a is a negative regulator of IL-33–ST2 signaling. In vivo, miR-146a expression in plasma exosomes was elevated after i.p. injection of IL-33 in wild-type but not mast cell–deficient KitW-sh/W-sh mice. Finally, KitW-sh/W-sh mice acutely reconstituted with miR-146a knockout BMMCs prior to IL-33 challenge had elevated plasma IL-6 levels compared with littermates receiving wild-type BMMCs. These results support the hypothesis that miR-146a is a feedback regulator of IL-33–mediated mast cell functions associated with allergic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biology, Virginia Commonwealth University, Richmond, VA.
- Center for Shock, Trauma and Anesthesiology Research, University of Maryland School of Medicine, Baltimore, MD.
ORCID-Profile: Heather L Caslin, Boyang Ren, Wei Chao, Lin Zou, David Straus
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
- Foundation for the National Institutes of Health
Zitieren
APA
Taruselli, M. T., Abdul Qayum, A., Abebayehu, D., Caslin, H. L., Dailey, J. M., Kotha, A., Burchett, J. R., Kee, S. A., Maldonado, T. D., Ren, B., Chao, W., Zou, L., Haque, T. T., Straus, D., & Ryan, J. J. (2024). IL-33 Induces Cellular and Exosomal miR-146a Expression as a Feedback Inhibitor of Mast Cell Function. The Journal of Immunology, 212(8), 1277-1286. https://doi.org/10.4049/jimmunol.2200916
Vancouver
Taruselli MT, Abdul Qayum A, Abebayehu D, Caslin HL, Dailey JM, Kotha A, et al. IL-33 Induces Cellular and Exosomal miR-146a Expression as a Feedback Inhibitor of Mast Cell Function. The Journal of Immunology. 2024;212(8):1277-1286. doi:10.4049/jimmunol.2200916
BibTeX
@article{Taruselli2024,
author = {Taruselli, Marcela T and Abdul Qayum, Amina and Abebayehu, Daniel and Caslin, Heather L and Dailey, Jordan M and Kotha, Aditya and Burchett, Jason R and Kee, Sydney A and Maldonado, Tania D and Ren, Boyang and Chao, Wei and Zou, Lin and Haque, Tamara T and Straus, David and Ryan, John J},
title = {IL-33 Induces Cellular and Exosomal miR-146a Expression as a Feedback Inhibitor of Mast Cell Function},
journal = {The Journal of Immunology},
year = {2024},
volume = {212},
number = {8},
pages = {1277--1286},
doi = {10.4049/jimmunol.2200916}
}
EUVIMED